Updated Jan 21, 2008 at 8:58 EST.
Johnson & Johnson will have their annual meeting on Tuesday January 22 at 8:30 a. m. EST.
They are planning to review their 4rd quarter and full year 2007 financial results.
Johnson & Johnson is well known for their achievements combating premature ejaculation.
They have been developing Dapoxetine ( Prilogy ™ ).
This is foreseen to be the leading premature ejaculation treatment doctors and patients will choose when trying to combat the sexual disorder.
The webcast and podcast of the annual meeting will be available two hours after the meeting ends on
http://www.investor.jnj.com.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
